To date, DragonFly™ has received regulatory approvals in 15 countries and regions, with routine clinical use and commercial adoption already underway in key international markets including Latin America and Southeast Asia
We also strive to provide a distinctive perspective on the rapidly evolving healthcare landscape. By staying connected with our reporting, you gain access to exclusive insights on industry developments, emerging technologies, and global regulatory changes that influence the medical device sector. At the same time, you join a vibrant community of professionals, innovators, and thought leaders dedicated to advancing healthcare through cutting‑edge solutions.
We invite you to explore our wide range of content—from the latest product announcements to detailed analyses of industry trends. And if our mission aligns with your goals, we offer opportunities for advertising and collaboration, helping you connect with a highly engaged audience of medical technology professionals.
Definition medical devices.
Latest Developments, Breakthroughs & Future Outlook
To date, DragonFly™ has received regulatory approvals in 15 countries and regions, with routine clinical use and commercial adoption already underway in key international markets including Latin America and Southeast Asia
The milestone procedure was performed by world-renowned interventional cardiologist Alan Zajarias, MD, in St. Louis, Missouri.
A milestone in the collaboration announced in March 2026, this Agentic AI development demonstrates advancement of Tecan and NVIDIA’s shared vision of enabling Data-Driven Laboratories with AI-powered platforms designed to accelerate scientific discovery and improve laboratory productivity
New generation catheters integrating SlipStream™ technology and patented insertion system now available to healthcare professionals in Canada, reinforcing Vygon’s extensive range in vascular access devices
Michael Nagel, Chief Executive Officer of Raydiant Oximetry. "The FDA's authorization to expand enrollment is an important milestone for the program. We look forward to continuing our collaboration with LSUHS as we build the clinical and technical foundation for an entirely new generation of fetal monitoring technologies."
Prospective, multicenter trial will evaluate a novel preservation technique utilizing the Paragonix SherpaPak® for DCD (Donation after Circulatory Death) hearts
The ongoing HIVEC HEAT trial aims to generate clinical data to evidence the efficacy of hyperthermic intravesical 80mg mitomycin C chemotherapy for patients with BCG-unresponsive, high risk NMIBC
The program supports early tolerability assessment, PK/TK-linked safety evaluation, immune-related risk screening, and pre-GLP dose design for biologics and immunomodulatory drug programs
"This agreement further strengthens ALZpath's leadership in blood-based Alzheimer's testing and reinforces our position as the foundational component supporting the overwhelming majority of the pTau217 IVD market," said Mike Banville, CEO of ALZpath.
Class C software-only IVD supports European rollout of a JCO-published assay designed to bring clinically validated prognostic assessment into routine breast cancer care
CellLife notes the licensing agreement builds on their existing proprietary dendritic cell platform, which has demonstrated long-term durability in preventing relapse in pediatric patients with metastatic bone cancer in a Phase I clinical study conducted at leading institutions in Europe
Acquisition delivers simplicity and access, supporting physicians across the full procedural workflow
The acquisition will expand Otsuka’s continued investment in emerging, next-generation neuropsychiatric treatments for serious mental illness
Upon completion of the transaction, Ernest Health will expand its footprint from 38 to 45 medical rehabilitation hospitals across the United States
Through the program, Auxilium will invest a total of $1 million across the cohort, with each company receiving a $250,000 investment to help accelerate growth beyond early validation
Ingenix's Biological Reasoning Engine fuses biological data through Modality Fusion, a new architecture for AI in drug development
Financing supports the approval of U.S. Investigational Device Exemption (IDE), coronary clinical advancement, and expansion into below-the-knee peripheral (BTK) applications
By Yuri Nikolsky, Ph.D., D.A.B.R.M. University of Sharjah, Department of Medicine. University City, Sharjah, UAE. ynikolsky@sharjah.ac.ae
By: David Garratt, Principal Consultant - Automated IT Governance, Risk, Compliance, Verista
Katherine Klyushnichenko DiogeneAge, Inc. 1910 Thomes Avenue, Cheyenne, Wyoming 82001-3527, USA | kathy@diogeneage.com
While many regenerative treatments rely on injections administered in specialized clinics, his cream is designed to offer a non-invasive alternative
The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the skin using dissolvable Doxorubicin-containing Microneedle arrays (D-MNA) representing ~$2 billion in potential market opportunity
he Quantra Hemostasis System provides comprehensive blood analysis that delivers rapid, real-time coagulation insights at the point of need, empowering clinicians with actionable data to make better decisions and protect mothers who experience postpartum hemorrhage during childbirth. Quantra is the first and only cartridge-based FDA-cleared viscoelastic testing platform for obstetrics
Brian Hart will drive Advarra’s technology and product strategy, bringing continuous innovation to the development and enhancement of Advarra’s solutions.
Founder Greg Sullivan will transition into the role of Chief Technology Officer to focus on advancing MMS’s technology platform, next-generation product development, and clinical evidence initiatives.
Effective August 25, 2025.
Experienced surgeon to provide cross-functional guidance as company focuses on future growth and innovation.
The latest updates to these ESC guidelines emphasize the robust clinical evidence supporting the use of intravascular ultrasound (IVUS) and instantaneous wave-free ratio (iFR), both of which have demonstrated significant benefits in improving patient outcomes through numerous large-scale randomized trials like DEFINE FLAIR and iFR SWEDEHEART. The updates were announced at the recent ESC Congress in London, five years after the last update in 2019, and simultaneously published in the European Heart Journal.
Under the terms of the agreement, Bracco Imaging will supply Arrayus with microbubbles for use in the development and commercialization of its focused ultrasound platform for pancreatic cancer.
The study conducted at the Phrapokklao Hospital’s Cancer Centre of Excellence in Bangkok, Thailand was led by Dr Passakorn Wanchaijiraboon, Medical Oncologist and Deputy Director using the Qure.ai chest X-ray AI solution qXR.
This is a summary of a study using the Reveal 35C detector in the ICU, to be presented at this year’s American Society of Emergency Radiology Meeting reports KA Imaging.
New research presented at the 2026 SOSORT International Congress in Italy demonstrates the power of custom 3D bracing and consistent patient care
Nonprofit reaches milestone of facilitating 150,000 transplants giving patients a second chance at life, thanks to federal investment in and Congressional commitment to the C.W. Bill Young Cell Transplantation Program
The current outbreak involves the Bundibugyo strain of Ebola virus, for which no approved vaccines or therapeutics currently exist, heightening concerns among global health officials and frontline responders, according to reporting by Health Policy Watch
More extractables work as combination products grow, more scrutiny on data integrity, more pressure to ship validation packages faster. So here's the question worth sitting with: when your next 510(k) or PMA hinges on a column of impurity data, do you actually know whether the instrument that generated it is still performing...
A secure and efficient supply chain is essential for the delivery of safe medical treatments. By prioritizing environmental controls, total traceability, and strict fulfillment accuracy, specialized logistics providers ensure that vital medications remain safe and effective
Learn how plastic surgeons can optimize their Google Business Profile, improve local search rankings, attract more patients, and grow their practice online
This employment toolkit is designed to walk a new occupational therapy (OT) graduate through the process of landing their first job in healthcare
Choosing a graduate business program today is not just about prestige. It is about outcomes, flexibility, and relevance in a world shaped by AI, remote work, and economic uncertainty.
Education is more than a requirement in healthcare; it is the key that unlocks opportunity, stability, and purpose.
Accelerated BSN programs offer a rapid pathway into nursing for those with prior degrees and these programs help address the nationwide nursing shortage by quickly preparing qualified professionals.
Burnout isn’t just “being tired.” It’s a chronic state of emotional, mental, and physical exhaustion caused by prolonged stress.
Many nurses manage to stay in great shape, both physically and mentally—despite the challenges
Medical Device News Magazine uses cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google Tag Manager simplifies the management of marketing tags on your website without code changes.
You can find more information in our Cookie Policy: Medical Device NewsMagazine and PRIVACY.